EC authorizes Pfizer’s PREVENAR 20 vaccine for pediatric Use

In a landmark decision, Pfizer Inc. (NYSE: PFE) has been granted marketing authorization by the European Commission (EC) for its 20-valent pneumococcal conjugate vaccine, PREVENAR ... Read More